Iterum Therapeutics Announces $20M Share Offering
I'm PortAI, I can summarize articles.
Iterum Therapeutics (ITRM) announced a $20 million share offering under its at-the-market agreement on October 16, 2025. The company has previously raised $36.2 million through similar offerings. Despite launching ORLYNVAH™ in the U.S. in August 2025, the company faces financial challenges, including ongoing net losses. Analysts rate ITRM as a Buy with a $5.00 price target, but Spark's AI Analyst considers it an Underperform due to weak market momentum and strategic uncertainties. Iterum's current market cap is $32.94 million.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Tip Ranks The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments